The Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism Did Not Influence Growth Response to Growth Hormone Therapy over Two Years in Prepubertal Short Children Born at Term with Adequate Weight and Length for Gestational Age | Zendy

Antonio Carrascosa | Zendy; Laura Audı́ | Zendy; Mónica FernándezCancio | Zendy; Cristina Estéban | Zendy; Pilar Andaluz | Zendy; E. Vilaró | Zendy; María Clemente | Zendy; Diego Yeste | Zendy; M. Albisu | Zendy; Miquel Gussinyé | Zendy

Open Access

The Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism Did Not Influence Growth Response to Growth Hormone Therapy over Two Years in Prepubertal Short Children Born at Term with Adequate Weight and Length for Gestational Age

Author(s) -

Antonio Carrascosa,

Laura Audı́,

Mónica FernándezCancio,

Cristina Estéban,

Pilar Andaluz,

E. Vilaró,

María Clemente,

Diego Yeste,

M. Albisu,

Miquel Gussinyé

Publication year - 2007

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2007-2180

Subject(s) - growth hormone , exon , endocrinology , term (time) , medicine , hormone , polymorphism (computer science) , growth hormone receptor , biology , oncology , genetics , gene , genotype , physics , quantum mechanics

Consensus is lacking as to whether the exon 3-deleted (d3)/full-length (fl) GH receptor (GHR) polymorphism is associated with responsiveness to GH therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research